1 / 54

Anatomy and Treatment of Cardiovascular Conditions

Learn about the anatomy of the heart and common cardiovascular conditions such as hypertension, congestive heart failure, and coronary artery disease. Explore the different pharmaceutical treatments available for these conditions.

Download Presentation

Anatomy and Treatment of Cardiovascular Conditions

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Chapter 26 The Cardiovascular, Circulatory, and Lymph Systems

  2. Figure 26.1 The heart.

  3. Anatomy of the Heart • Composed of four chambers: two upper and two lower • Atria—top two chambers • Ventricles—bottom two chambers • Septum—divides heart into right and left sides

  4. Valves of the Heart • Tricuspid valve—located between the right atrium and the right ventricle • Pulmonary valve—located between the right ventricle and the pulmonary artery • Mitral or bicuspid valve—located between the left atrium and the left ventricle • Aortic valve—located between the left ventricle and the aorta

  5. Layers of the Heart • Pericardium—fluid-filled sac that surrounds and protects the heart • Permits free movement of the heart during contraction • Endocardium—innermost wall layer; covers the inside surface of the heart • Myocardium—surrounds heart and causes chamber contractions

  6. Figure 26.2 Blood flow through the heart.

  7. Function of the Heart • Provides oxygenated blood throughout the body by a pumping mechanism • Oxygenated blood deposits materials necessary for growth and nourishment • Receives from tissues the waste products resulting from metabolism

  8. Hypertension • Sustained elevation of systemic arterial blood pressure • Symptoms include: • Severe headache • Chest pain • Irregular heartbeat • Fatigue

  9. Hypertension (cont.) • Pharmaceutical treatment includes diuretics, vasodilators, ACE inhibitors, beta blockers, and calcium channel blockers

  10. Congestive Heart Failure • Heart pumps out less blood than it receives • Results in weakened and enlarged heart

  11. Congestive Heart Failure (cont.) • Symptoms of CHF include: • Upright posture or leaning forward • Anxiety and restlessness • Cyanotic and clammy skin • Persistent cough • Rapid breathing • Fast heart rate • Edema of the lower limbs

  12. Congestive Heart Failure (cont.) • Pharmaceutical treatment includes cardiac glycosides, diuretics, vasodilators, ACE inhibitors, beta-adrenergic blockers, and phosphodiesterase inhibitors

  13. Coronary Artery Disease • Occurs when there is insufficient blood flow to the heart • Can lead to: • Angina • Heart attack • Arrythmias • Stroke • Pulmonary embolism • Heart failure

  14. Coronary Artery Disease (cont.) • Pharmaceutical treatment includes platelet aggregation inhibitors, anticoagulants, tissue plasminogen activators, and thrombin inhibitors

  15. Cardiovascular Pharmaceuticals • Antiarrhythmic drugs—restore normal rhythm patterns but do not cure the cause of the irregular heartbeat • Cardiac glycosides—used to increase the force of myocardial contraction, without causing an increase in the consumption of oxygen

  16. Cardiovascular Pharmaceuticals (cont.) • Diuretics—used to eliminate excess sodium and water via the urinary tract • Vasodilators—allow more blood to exit the heart, preventing or mitigating congestion; lower blood pressure

  17. Cardiovascular Pharmaceuticals (cont.) • Angiotensin-converting enzyme inhibitors (ACE inhibitors)—lower high blood pressure; thought to reshape the heart; prevent the body from producing natural vasodilators • Angiotensin II receptor blockers—similar to ACE inhibitors; block the body’s natural vasodilators

  18. Cardiovascular Pharmaceuticals (cont.) • Beta-adrenergic blockers—used to block cells from receiving natural vasoconstrictors • Antiadrenergic agents—interfere with the manufacture of vasoconstrictors at nerve endings • Platelet aggregation inhibitors—reduce the ability of the blood to coagulate

  19. Cardiovascular Pharmaceuticals (cont.) • Anticoagulants—prevent clots from forming or existing clots from getting bigger • Tissue plasminogen activators—break down blood clots by reversing the clotting order and interfering with the synthesis of various clotting factors

  20. Cardiovascular Pharmaceuticals (cont.) • Thrombin inhibitors—inactivate bound thrombin by binding to the enzyme and blocking its interaction with its substrates of fibrin • Antihyperlipidemics—help prevent the progression of coronary artery disease by lowering plasma lipid levels

  21. Anticoagulants • Do not thin out the blood • Prevent clots from forming • Prevent existing clots from getting bigger • Cannot dissolve existing blood clots

  22. Warfarin • Oral drug of choice • Works by preventing the synthesis of clotting factors II, VII, IX, and X

  23. Warfarin (cont.) • Used in the long-term prevention or management of venous thromboembolic disorders, including: • Deep vein thrombosis • Pulmonary embolism • Clotting associated with atrial fibrillation and prosthetic heart valves • Vitamin K may be used as an antidote when too much warfarin has been given

  24. Heparin • Parenterally administered drug of choice • Works by inactivating clotting factors IX, X, XI, and XII • Used prophylactically to: • Prevent and treat deep vein thrombosis • Prevent and treat pulmonary embolism • Treat thrombophlebitis • Prevent clotting during cardiac and vascular surgery

  25. Heparin (cont.) • The only antidote for heparin overdose is protamine sulfate

  26. Table 26.2 Antiarrhythmic Agents

  27. Table 26.2 (continued) Antiarrhythmic Agents

  28. Table 26.2 (continued) Antiarrhythmic Agents

  29. Table 26.2 (continued) Antiarrhythmic Agents

  30. Table 26.3 Thiazide Diuretics

  31. Table 26.4 Loop Diuretics

  32. Table 26.5 Potassium Sparing Diuretics

  33. Table 26.7 Peripheral Vasodilators

  34. Table 26.8 Coronary Vasodilators

  35. Table 26.9 Angiotensin-Converting Enzyme Inhibitors

  36. Table 26.9 (continued) Angiotensin-Converting Enzyme Inhibitors

  37. Table 26.9 (continued) Angiotensin-Converting Enzyme Inhibitors

  38. Table 26.10 Angiotensin II Receptor Blockers (Angiotensin II Antagonists)

  39. Table 26.11 Nonselective Beta-Adrenergic Blocking Agents

  40. Table 26.12 Selective Beta-Adrenergic Blocking Agents

  41. Table 26.13 Antiadrenergic Agents

  42. Table 26.14 Antiplatelet Agents

  43. Table 26.15 Comparison of Antiplatelet Agents

  44. Table 26.15 (continued) Comparison of Antiplatelet Agents

  45. Table 26.16 Anticoagulants

  46. Table 26.17 Thrombolytics and Tissue Plasminogen Activators

  47. Table 26.18 Thrombin Inhibitors

  48. Cholesterol and Triglycerides • HDL—high-density lipoproteins or “good” cholesterol • LDL—low-density lipoproteins or “bad” cholesterol • Triglycerides—a form of energy stored in adipose and muscle tissues • Often measured to depict fat ingestion and metabolism • Can be used to assess CAD risk factors

  49. Table 26.19 Total Cholesterol Levels

  50. Table 26.20 High-Density Lipid (HDL) Levels (Good Cholesterol)

More Related